Evidence map›Paper›PMID 26568960›Full record

ArticleJournal of immunology research2015

Nonbilayer Phospholipid Arrangements Are Toll-Like Receptor-2/6 and TLR-4 Agonists and Trigger Inflammation in a Mouse Model Resembling Human Lupus.

Carlos Wong-Baeza, Alonso Tescucano, Horacio Astudillo, Albany Reséndiz, Carla Landa, Luis España, Jeanet Serafín-López, Iris Estrada-García, Sergio Estrada-Parra, Leopoldo Flores-Romo and 2 more

Open access · goldAbstract read
In one paragraph

Article in Journal of immunology research, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Anti-Lipid IgG Antibodies Are ProducedFrontiers in immunology · 2016
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Carlos Wong-BaezaBiochemistry Department, National School of Biological Sciences, National Polytechnic Institute (IPN), 11340 Mexico City, DF, Mexico ; Cell Biology Department, Center for Research and Advanced Studies of the National Polytechnic Institute (IPN), 07360 Mexico City, DF, Mexico.
Alonso TescucanoBiochemistry Department, National School of Biological Sciences, National Polytechnic Institute (IPN), 11340 Mexico City, DF, Mexico.
Horacio AstudilloOncology Department, Mexican Institute of Social Security, XXI Century National Medical Center, 06720 Mexico City, DF, Mexico.
Albany ReséndizBiochemistry Department, National School of Biological Sciences, National Polytechnic Institute (IPN), 11340 Mexico City, DF, Mexico.
Carla LandaBiochemistry Department, National School of Biological Sciences, National Polytechnic Institute (IPN), 11340 Mexico City, DF, Mexico.
Luis EspañaBiochemistry Department, National School of Biological Sciences, National Polytechnic Institute (IPN), 11340 Mexico City, DF, Mexico.
Jeanet Serafín-LópezImmunology Department, National School of Biological Sciences, National Polytechnic Institute (IPN), 11340 Mexico City, DF, Mexico.
Iris Estrada-GarcíaImmunology Department, National School of Biological Sciences, National Polytechnic Institute (IPN), 11340 Mexico City, DF, Mexico.
Sergio Estrada-ParraImmunology Department, National School of Biological Sciences, National Polytechnic Institute (IPN), 11340 Mexico City, DF, Mexico.
Leopoldo Flores-RomoCell Biology Department, Center for Research and Advanced Studies of the National Polytechnic Institute (IPN), 07360 Mexico City, DF, Mexico.
Carlos WongBiochemistry Department, National School of Biological Sciences, National Polytechnic Institute (IPN), 11340 Mexico City, DF, Mexico.
Isabel BaezaBiochemistry Department, National School of Biological Sciences, National Polytechnic Institute (IPN), 11340 Mexico City, DF, Mexico.
Tecnológico Nacional de México · MXInstituto Politécnico Nacional · MXMexican Social Security Institute · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Systemic lupus erythematosus is characterized by dysregulated activation of T and B cells and autoantibodies to nuclear antigens and, in some cases, lipid antigens. Liposomes with nonbilayer phospholipid arrangements induce a disease resembling human lupus in mice, including IgM and IgG antibodies against nonbilayer phospholipid arrangements. As the effect of these liposomes on the innate immune response is unknown and innate immune system activation is necessary for efficient antibody formation, we evaluated the effect of these liposomes on Toll-like receptor (TLR) signaling, cytokine production, proinflammatory gene expression, and T, NKT, dendritic, and B cells. Liposomes induce TLR-4- and, to a lesser extent, TLR-2/TLR-6-dependent signaling in TLR-expressing human embryonic kidney (HEK) cells and bone marrow-derived macrophages. Mice with the lupus-like disease had increased serum concentrations of proinflammatory cytokines, C3a and C5a; they also had more TLR-4-expressing splenocytes, a higher expression of genes associated with TRIF-dependent TLR-4-signaling and complement activation, and a lower expression of apoptosis-related genes, compared to healthy mice. The percentage of NKT and the percentage and activation of dendritic and B2 cells were also increased. Thus, TLR-4 and TLR-2/TLR-6 activation by nonbilayer phospholipid arrangements triggers an inflammatory response that could contribute to autoantibody production and the generation of a lupus-like disease in mice.

Indexed as

AnimalsAutoantibodiesChlorpromazineCytokinesDiglyceridesDisease Models, AnimalFemaleFlagellinGene Expression RegulationHEK293 CellsHumansImmunoglobulin GImmunoglobulin MInflammationLipopolysaccharidesLiposomesAutoantibodiesChlorpromazineCytokinesDiglyceridesFlagellinFSL-1 lipoprotein, syntheticImmunoglobulin GImmunoglobulin MLipopolysaccharidesLiposomesOligopeptidesPhosphatidic AcidsPhosphatidylcholinesPhosphatidylserinesTLR2 protein, humanTLR4 protein, humanTLR6 protein, humanToll-Like Receptor 2Toll-Like Receptor 4Toll-Like Receptor 6

Identifiers

PMID26568960
PMCPMC4629040
OpenAlexW2102214879

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.